Patients with aminoglycoside therapy should be monitored for:

A. "You have developed urticaria in response to something in your environment."
This statement is incorrect. Urticaria refers to hives, a skin rash usually caused by an allergic reaction, infection, or stress. It's not necessarily indicative of an autoimmune disease.

B. "Your immune system is creating antibodies that are destroying your own cells."
This statement is correct. Autoimmune diseases involve the immune system mistakenly attacking the body's own cells and tissues, leading to various health issues.

C. "Your immune system is not able to create antibodies to help you fight infection."
This statement is incorrect. In autoimmune diseases, the immune system is overactive, producing antibodies that target the body's own cells, not that it can't create antibodies.

D. "You have developed an infection that is destroying your immune cells."
This statement is incorrect. Infections don't typically destroy immune cells; instead, infections often stimulate the immune system to respond and fight against invading pathogens.

A. "Cephalosporins are assigned to generations based on their relative costs to administer."
This statement is incorrect. The classification of cephalosporins into generations is based on their antimicrobial spectrum and activity against specific bacteria, not their cost.

B. "Later generations of cephalosporins have lower resistance to destruction by beta-lactamases."
This statement is not accurate. In fact, later generations of cephalosporins have increased resistance to destruction by beta-lactamases, which are enzymes produced by bacteria that can break down certain antibiotics.

C. "Cephalosporins have increased activity against gram-negative bacteria with each new generation."
This statement is correct. Cephalosporins are grouped into generations (first to fifth) based on their antibacterial spectrum. As the generations progress, there is an increase in activity against gram-negative bacteria, among other improvements in their spectrum.

D. "First-generation cephalosporins have better penetration of the cerebrospinal fluid."
This statement is generally true. First-generation cephalosporins have better penetration into the cerebrospinal fluid, making them useful for treating certain central nervous system infections.